Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

181.01  -0.53 (-0.29%)

After market: 181.01 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MYRG. MYRG was compared to 49 industry peers in the Construction & Engineering industry. MYRG is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MYRG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MYRG had positive earnings in the past year.
In the past year MYRG had a positive cash flow from operations.
MYRG had positive earnings in each of the past 5 years.
In the past 5 years MYRG always reported a positive cash flow from operatings.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

MYRG has a Return On Assets (4.81%) which is comparable to the rest of the industry.
MYRG has a Return On Equity of 13.10%. This is in the better half of the industry: MYRG outperforms 61.22% of its industry peers.
MYRG has a better Return On Invested Capital (10.00%) than 67.35% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MYRG is significantly below the industry average of 16.87%.
The 3 year average ROIC (8.30%) for MYRG is below the current ROIC(10.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.81%
ROE 13.1%
ROIC 10%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MYRG's Profit Margin of 2.21% is in line compared to the rest of the industry. MYRG outperforms 46.94% of its industry peers.
MYRG's Profit Margin has declined in the last couple of years.
MYRG has a Operating Margin (3.45%) which is comparable to the rest of the industry.
MYRG's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 10.54%, MYRG is not doing good in the industry: 69.39% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of MYRG has declined.
Industry RankSector Rank
OM 3.45%
PM (TTM) 2.21%
GM 10.54%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MYRG is destroying value.
Compared to 1 year ago, MYRG has less shares outstanding
The number of shares outstanding for MYRG has been reduced compared to 5 years ago.
MYRG has a worse debt/assets ratio than last year.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 4.68. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
MYRG has a better Altman-Z score (4.68) than 75.51% of its industry peers.
The Debt to FCF ratio of MYRG is 0.82, which is an excellent value as it means it would take MYRG, only 0.82 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.82, MYRG belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that MYRG is not too dependend on debt financing.
MYRG has a Debt to Equity ratio of 0.14. This is amongst the best in the industry. MYRG outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.82
Altman-Z 4.68
ROIC/WACC0.91
WACC11.05%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.33 indicates that MYRG should not have too much problems paying its short term obligations.
The Current ratio of MYRG (1.33) is comparable to the rest of the industry.
A Quick Ratio of 1.33 indicates that MYRG should not have too much problems paying its short term obligations.
The Quick ratio of MYRG (1.33) is better than 61.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

MYRG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.92%.
The Earnings Per Share has been growing by 8.67% on average over the past years. This is quite good.
The Revenue has decreased by -3.80% in the past year.
The Revenue has been growing by 10.17% on average over the past years. This is quite good.
EPS 1Y (TTM)6.92%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%161.54%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%1.38%

3.2 Future

The Earnings Per Share is expected to grow by 45.56% on average over the next years. This is a very strong growth
MYRG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.94% yearly.
EPS Next Y98.62%
EPS Next 2Y55.25%
EPS Next 3Y45.56%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y4.43%
Revenue Next 3Y6.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 37.79, MYRG can be considered very expensive at the moment.
MYRG's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of MYRG to the average of the S&P500 Index (26.87), we can say MYRG is valued slightly more expensively.
With a Price/Forward Earnings ratio of 22.02, MYRG is valued on the expensive side.
Based on the Price/Forward Earnings ratio, MYRG is valued a bit cheaper than the industry average as 65.31% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, MYRG is valued a bit cheaper.
Industry RankSector Rank
PE 37.79
Fwd PE 22.02
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

63.27% of the companies in the same industry are more expensive than MYRG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MYRG is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.86
EV/EBITDA 15.57
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYRG's earnings are expected to grow with 45.56% in the coming years.
PEG (NY)0.38
PEG (5Y)4.36
EPS Next 2Y55.25%
EPS Next 3Y45.56%

More info and screens

0

5. Dividend

5.1 Amount

MYRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (8/15/2025, 8:00:01 PM)

After market: 181.01 0 (0%)

181.01

-0.53 (-0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners102.94%
Inst Owner Change-0.77%
Ins Owners1.75%
Ins Owner Change2.83%
Market Cap2.81B
Analysts85.45
Price Target208.9 (15.41%)
Short Float %4.41%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.94%
Max EPS beat(2)18.63%
EPS beat(4)4
Avg EPS beat(4)37.97%
Min EPS beat(4)9.94%
Max EPS beat(4)84.18%
EPS beat(8)5
Avg EPS beat(8)27.58%
EPS beat(12)8
Avg EPS beat(12)23.36%
EPS beat(16)11
Avg EPS beat(16)19.18%
Revenue beat(2)2
Avg Revenue beat(2)4.77%
Min Revenue beat(2)3.99%
Max Revenue beat(2)5.55%
Revenue beat(4)2
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)5.55%
Revenue beat(8)4
Avg Revenue beat(8)-0.18%
Revenue beat(12)8
Avg Revenue beat(12)3.53%
Revenue beat(16)11
Avg Revenue beat(16)2.56%
PT rev (1m)20.61%
PT rev (3m)28.67%
EPS NQ rev (1m)4.04%
EPS NQ rev (3m)15.6%
EPS NY rev (1m)0%
EPS NY rev (3m)9.68%
Revenue NQ rev (1m)-0.39%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.04%
Valuation
Industry RankSector Rank
PE 37.79
Fwd PE 22.02
P/S 0.81
P/FCF 25.86
P/OCF 16.25
P/B 4.82
P/tB 7.15
EV/EBITDA 15.57
EPS(TTM)4.79
EY2.65%
EPS(NY)8.22
Fwd EY4.54%
FCF(TTM)7
FCFY3.87%
OCF(TTM)11.14
OCFY6.15%
SpS222.41
BVpS37.58
TBVpS25.3
PEG (NY)0.38
PEG (5Y)4.36
Profitability
Industry RankSector Rank
ROA 4.81%
ROE 13.1%
ROCE 14.51%
ROIC 10%
ROICexc 10.29%
ROICexgc 13.52%
OM 3.45%
PM (TTM) 2.21%
GM 10.54%
FCFM 3.15%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score6
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.82
Debt/EBITDA 0.45
Cap/Depr 97.93%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 93.63%
Profit Quality 142.23%
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 4.68
F-Score6
WACC11.05%
ROIC/WACC0.91
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.92%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%161.54%
EPS Next Y98.62%
EPS Next 2Y55.25%
EPS Next 3Y45.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%1.38%
Revenue Next Year2.75%
Revenue Next 2Y4.43%
Revenue Next 3Y6.94%
Revenue Next 5YN/A
EBIT growth 1Y74.74%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year403.96%
EBIT Next 3Y88.24%
EBIT Next 5YN/A
FCF growth 1Y211.75%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y40.32%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%